Kezar Life Sciences, Inc. (KZR)
NASDAQ: KZR · Real-Time Price · USD
6.03
-0.03 (-0.49%)
At close: Feb 5, 2026, 4:00 PM EST
6.03
0.00 (0.00%)
After-hours: Feb 5, 2026, 4:10 PM EST
Kezar Life Sciences Market Cap
Kezar Life Sciences has a market cap or net worth of $44.16 million as of February 5, 2026. Its market cap has decreased by -4.39% in one year.
Market Cap
44.16M
Enterprise Value
-36.14M
1-Year Change
-4.39%
Ranking
Category
Stock Price
$6.03
Market Cap Chart
Since June 21, 2018, Kezar Life Sciences's market cap has decreased from $325.21M to $44.16M, a decrease of -86.42%. That is a compound annual growth rate of -23.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 44.38M | -3.66% |
| Dec 31, 2025 | 46.06M | -6.05% |
| Dec 31, 2024 | 49.03M | -28.81% |
| Dec 29, 2023 | 68.87M | -85.69% |
| Dec 30, 2022 | 481.38M | -41.42% |
| Dec 31, 2021 | 821.73M | 240.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 48.29M |
| NeurAxis | 46.34M |
| LeonaBio | 45.42M |
| PDS Biotechnology | 44.87M |
| ABVC BioPharma | 44.78M |
| CEL-SCI | 44.73M |
| Cingulate | 44.17M |
| CervoMed | 43.77M |